✦ LIBER ✦

Pharmacokinetics and safety of tamsulosin in subjects with normal and impaired renal or hepatic function

✍ Scribed by Yasushi Miyazawa; Robert A. Blum; Jerome J. Schentag; Hidetaka Kamimura; Hiroshi Matsushima; Herbert Swarz; Yutaka Ito

Book ID: 117090196
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 892 KB
Volume: 62
Category: Article
ISSN: 0011-393X
DOI: 10.1016/s0011-393x(01)80067-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics of naproxen in subjects

Pharmacokinetics of naproxen in subjects with normal and impaired renal function

✍ M. Anttila; M. Haataja; A. Kasanen 📂 Article 📅 1980 🏛 Springer 🌐 English ⚖ 473 KB

Single-Dose Pharmacokinetics of Boceprev

Single-Dose Pharmacokinetics of Boceprevir in Subjects with Impaired Hepatic or Renal Function

✍ Dr Michelle Treitel, Thomas Marbury, Richard A. Preston, Ilias Triantafyllou, Wi 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 193 KB

Pharmacokinetics of Cefoperazone in Pati

Pharmacokinetics of Cefoperazone in Patients with Normal and Impaired Hepatic and Renal Function

✍ Greenfield, R. A.; Gerber, A. U.; Craig, W. A. 📂 Article 📅 1983 🏛 University of Chicago Press 🌐 English ⚖ 879 KB

Pharmacokinetic and pharmacodynamic prop

Pharmacokinetic and pharmacodynamic properties of eptifibatide in subjects with normal or impaired renal function

✍ Daniel D. Gretler; Roberto Guerciolini; Paul J. Williams 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 127 KB

Pharmacokinetics of Vandetanib in Subjec

Pharmacokinetics of Vandetanib in Subjects with Renal or Hepatic Impairment

✍ Angelika Weil, Dr Paul Martin, Robert Smith, Stuart Oliver, Peter Langmuir, Jess 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 220 KB

Steady-state pharmacokinetics of nefazod

Steady-state pharmacokinetics of nefazodone in subjects with normal and impaired renal function

✍ R. H. Barbhaiya; M. E. Brady; U. A. Shukla; D. S. Greene 📂 Article 📅 1995 🏛 Springer 🌐 English ⚖ 604 KB

The steady-state pharmacokinetics of nefazodone (NEF) and its metabolites hydroxynefazodone (HO-NEF) and m-chlorophenylpiperazine (mCPP) were compared in subjects with normal and impaired renal function. Patients: The Study was of parallel group design which included 7 subjects with normal (NOR) ren